These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37821801)

  • 1. RFC2 promotes aerobic glycolysis and progression of colorectal cancer.
    Lou F; Zhang M
    BMC Gastroenterol; 2023 Oct; 23(1):353. PubMed ID: 37821801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPAG4 enhances mitochondrial respiration and aerobic glycolysis in colorectal cancer cells by activating the PI3K/Akt signaling pathway.
    Zhou J; Sun H; Zhou H; Liu Y
    J Biochem Mol Toxicol; 2024 Nov; 38(11):e70009. PubMed ID: 39410830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
    Li Q; Tang H; Hu F; Qin C
    J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.
    Li F; Wan X; Li Z; Zhou L
    Cancer Med; 2024 Jun; 13(11):e7382. PubMed ID: 38872380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
    Li Z; Jin Q; Sun Y
    J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
    Zhang Y; Wu Y; Su X
    Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
    [No Abstract]   [Full Text] [Related]  

  • 11. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin14 promotes colorectal cancer progression via the PI3K/AKT/mTOR pathway.
    Qiao TY; Yuan ZM; Ma TY; Hu HQ; Zhu YH; Zhang WY; Zhang Q; Huang R; Tang QC; Wang GY; Wang XS
    Neoplasma; 2021 Sep; 68(5):947-954. PubMed ID: 34156255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer.
    Tang C; Wang A; Zhao Y; Mou W; Jiang J; Kuang J; Sun B; Tang E
    Biomol Biomed; 2024 Jan; 24(4):968-981. PubMed ID: 38259082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
    Liu J
    Exp Cell Res; 2023 Sep; 430(1):113694. PubMed ID: 37391010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells.
    Hu T; Shen H; Li J; Yang P; Gu Q; Fu Z
    J Cell Physiol; 2020 Nov; 235(11):8319-8333. PubMed ID: 32239691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells.
    Li X; Tian R; Liu L; Wang L; He D; Cao K; Ma JK; Huang C
    J Int Med Res; 2020 Aug; 48(8):300060520946169. PubMed ID: 32787737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type Iγ phosphatidylinositol phosphate kinase promotes tumor growth by facilitating Warburg effect in colorectal cancer.
    Peng W; Huang W; Ge X; Xue L; Zhao W; Xue J
    EBioMedicine; 2019 Jun; 44():375-386. PubMed ID: 31105034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
    Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
    Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.